Efficacy definition

A monograph (1) covers the pioneering period of sulfa dmg development and describes over 5000 sulfanilamide derivatives, their preparation, properties, trade names, and biological testing. This review is remarkably complete through 1944. Several thousand additional derivatives have been made since, but no comparable coverage is available. A definitive account of medical appHcations up to 1960 has been pubHshed (2), and a review of experimental antibacterial aspects has been made (3). Chapters on general aspects of sulfonamides and sulfones have appeared (4,5). A review of the clinical efficacy of trimethoprim—sulfamethoxazole has been pubHshed (6). 

Negative efficacy, by definition, efficacy is that property of a molecule that causes the receptor to change its behavior toward the biological host. Negative efficacy refers to the property of selective affinity of the molecule for the inactive state of the receptor this results in inverse agonism. Negative efficacy causes the active antagonism of constitutive receptor activity but is only observed in systems that have a measurably elevated basal response due to constitutive activity. It is a property of the molecule and not the system. 

Allosteric antagonism definition of, 99 detection of, 140-142 with efficacy changes, 221-222 insurmoun table, 136-137 nature of, 127-129... 

Rational design, 148-149, 152 Real-time assays, 83, 88 Receptor(s). See also Drug receptors affinity for, 6, 63 allosteric model of, 143 Clark s work, 3 classical model of, 44-45 concept of, 2-4 conformations, 13-14, 13 Of conservation equation for, 76 constitutive activity of, 49-51 coupling of, 27 definition of, 2 desensitization of, 34 efficacy for, 6... 

There are few definitive data to substantiate the efficacy of LTRA therapy in refractory asthma, except for patients with aspirin-sensitive asthma. This is a fairly uncommon form of asthma that occurs generally in adults who often have no prior (i.e., childhood) history of asthma or atopy, may have nasal polyposis, and who often are dependent upon oral corticosteroids for control of their asthma. This syndrome is not specific to aspirin but is provoked by any inhibitors of the cycloxygenase-1 (COX-1) pathway. These patients have been shown to have a genetic defect that causes... 

The overall objective of clinical trials is to establish a drug therapy that is safe and effective in humans, to the extent that the risk-benefit relationship is acceptable. The ICH process has developed an internationally accepted definition of a clinical trial as Any investigation in human subjects intended to discover or verify the clinical, pharmacological and/or other pharmacodynamic effects of one or more investigational medicinal product(s), and/or to identify any adverse reactions to one or more investigational medicinal product(s) and/or to study absorption, distribution, metabolism and excretion of one or more investigational medicinal product(s) with the object of ascertaining its (their) safety and/or efficacy. ... 

In general, for smokers with cardiac disease, the benefits of nicotine replacement therapy outweigh the potential risks. In a safety and efficacy study that included veterans with cardiac disease, smoking concurrently with the nicotine patch was not associated with an increase in adverse events (Joseph et al. 1996). Although bupropion SR is generally well tolerated by smokers, it has not been adequately studied in persons with cardiac disease, and definitive conclusions regarding its safety in this patient population cannot currently be made (Society for Research on Nicotine and Tobacco 2003). 

Laboratory data are most often associated with safety analyses, but they may play a part in efficacy analyses as well, especially if the laboratory data are part of the clinical endpoint definition. From a CDISC perspective, laboratory data are a finding, as they are a planned assessment. 

The question whether lutein and zeaxanthin can contribute to lowering the risk for AMD cannot be answered unequivocally by epidemiological studies. Only randomized controlled trials (RCTs) during the course of which xanthophylls are supplemented in a double-blind, placebo-controlled, and randomized manner, and in which results are evaluated according to clear predefined efficacy criteria (Seddon and Hennekens 1994) have the potential to provide definitive answers. The specific long-term time-course and intricate nature of AMD make the design of such studies difficult, however. 

---